According to a Phase 3 noninferiority trial, 5% diquafosol eye drops demonstrate comparable efficacy and tolerability to 3% diquafosol for dry eye disease with a reduced dosing schedule. The double-blind,...

Topical azithromycin ophthalmic solution (Azyter, 15 mg/g) significantly improved disease symptoms and signs as second-line treatment for mixed dry eye disease (DED), according to a study. The prospective controlled pilot...

Adding a full-spectrum lamp to artificial tears improved subjective dry eye symptoms more in the short term in patients with visual display terminal (VDT)-related dry eye, but did not result... ...